Biomedical subjects

M Smecková

Publications and source records attributed to M Smecková.

17 recordsLinked to original sources

PubMed1989

Mild diabetic rubeosis and panretinal photocoagulation.

In a group of 32 treated and 20 untreated eyes of diabetics with proliferative retinopathy, we applied fluorescein angiography (FAC) of the iris for a period of 5 to 7 weeks to follow up the effect of panretinal photocoagulation (PRP) on mild diabetic rubeosis, which was considered to be a neovascularization of the iris on FAG smaller than 0.5 mm2 in the early phases of the angiogram. The evaluation was carried out by two independent examiners. In the treated group, an improvement occurred in 3 of 32 eyes, in the control group in 2 of 20 eyes. We did not find regression of mild rubeosis after PRP.

Diabetic Retinopathy↗

PubMed1989

Diabetic maculopathy and cataract extraction.

In 20 diabetic patients with diabetic retinopathy, we followed up the development of diabetic maculopathy after extraction. In 65% of the cases, the arisal or progression of the present macular edema was recorded 2 months after extraction together with a visual impairment. In 4 of them, the visual acuity adjusted itself within 10 months. The cause of this phenomenon may be traction of the vitreous body on the retina or the change in the hemodynamic conditions in the retina after cataract extraction. Since an improvement in the visual acuity occurs only in 30% of the involved eyes, it is recommended to apply the photocoagulation treatment on arisal or deepening of the edema.

Cataract Extraction↗

PubMed1989

Diabetic maculopathy and glaucoma.

Our group of 200 with laser treated diabetics included 5 patients (2.5%) with bilaterally treated primary simple glaucoma. All of them had diabetic maculopathy exclusively within the range of simple diabetic retinopathy. The focal type of maculopathy occurred 5 times, the cystoid 3 times, the ischemic once. There was emphasized the necessity to devote increased care to diabetics with glaucoma because for them glaucoma represents a risk factor regarding the further development of the visual function and the extent of the visual field. On the other hand, the decreased foveolar sensitivity in some diabetics with glaucoma may reduce the visual acuity which thus becomes an unreliable criterion of the success of the laser therapy.

Diabetic Retinopathy↗

PubMed1989

Smokers and diabetic maculopathy.

Of 200 examined diabetic patients with diabetic maculopathy there were 27 smokers, 23 of them diabetics of type II. In comparison with the control group of 23 diabetics with diabetic maculopathy-nonsmokers, the smokers showed a significantly higher incidence of the ischemic type of diabetic maculopathy which, however, did not manifest itself more markedly in their visual acuity.

Diabetic Retinopathy↗

PubMed1989

Treatment of perimacular proliferations in diabetic ophthalmopathy with fluorouracil.

Five eyes from 4 diabetic patients with proliferations perimacularly were treated with fluorouracil after previous unsuccessful treatment with laser therapy. Fluorouracil was administered in two series of five injections each, every second day in daily doses of 10 to 15 mg subconjunctivally. Fluorouracil was well tolerated. It has a certain inhibitory effect (both on vessels and particularly on the formation of the accompanying fibers) on proliferations reaching the macula at a distance from the vessels out of reach of the visual disc, it has no suppressing effect on papilloretinal proliferations.

Diabetic Retinopathy↗

PubMed1988